vs

Side-by-side financial comparison of BALCHEM CORP (BCPC) and COHEN & STEERS, INC. (CNS). Click either name above to swap in a different company.

BALCHEM CORP is the larger business by last-quarter revenue ($270.7M vs $143.8M, roughly 1.9× COHEN & STEERS, INC.). COHEN & STEERS, INC. runs the higher net margin — 24.3% vs 14.9%, a 9.4% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (8.1% vs 2.9%). BALCHEM CORP produced more free cash flow last quarter ($33.8M vs $-126.4M). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs 7.5%).

Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

BCPC vs CNS — Head-to-Head

Bigger by revenue
BCPC
BCPC
1.9× larger
BCPC
$270.7M
$143.8M
CNS
Growing faster (revenue YoY)
BCPC
BCPC
+5.2% gap
BCPC
8.1%
2.9%
CNS
Higher net margin
CNS
CNS
9.4% more per $
CNS
24.3%
14.9%
BCPC
More free cash flow
BCPC
BCPC
$160.3M more FCF
BCPC
$33.8M
$-126.4M
CNS
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
7.5%
BCPC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BCPC
BCPC
CNS
CNS
Revenue
$270.7M
$143.8M
Net Profit
$40.3M
$34.9M
Gross Margin
Operating Margin
20.5%
28.0%
Net Margin
14.9%
24.3%
Revenue YoY
8.1%
2.9%
Net Profit YoY
8.7%
-23.9%
EPS (diluted)
$1.25
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCPC
BCPC
CNS
CNS
Q1 26
$270.7M
Q4 25
$263.6M
$143.8M
Q3 25
$267.6M
$141.7M
Q2 25
$255.5M
$136.1M
Q1 25
$250.5M
$134.5M
Q4 24
$240.0M
$139.8M
Q3 24
$239.9M
$133.2M
Q2 24
$234.1M
$121.7M
Net Profit
BCPC
BCPC
CNS
CNS
Q1 26
$40.3M
Q4 25
$39.2M
$34.9M
Q3 25
$40.3M
$41.7M
Q2 25
$38.3M
$36.8M
Q1 25
$37.1M
$39.8M
Q4 24
$33.6M
$45.8M
Q3 24
$33.8M
$39.7M
Q2 24
$32.1M
$31.8M
Gross Margin
BCPC
BCPC
CNS
CNS
Q1 26
Q4 25
35.6%
Q3 25
35.7%
Q2 25
36.4%
Q1 25
35.2%
Q4 24
36.0%
Q3 24
35.6%
Q2 24
35.5%
Operating Margin
BCPC
BCPC
CNS
CNS
Q1 26
20.5%
Q4 25
19.8%
28.0%
Q3 25
20.4%
34.5%
Q2 25
20.1%
31.8%
Q1 25
20.4%
33.6%
Q4 24
19.8%
35.3%
Q3 24
20.0%
33.7%
Q2 24
19.6%
31.5%
Net Margin
BCPC
BCPC
CNS
CNS
Q1 26
14.9%
Q4 25
14.9%
24.3%
Q3 25
15.1%
29.4%
Q2 25
15.0%
27.1%
Q1 25
14.8%
29.6%
Q4 24
14.0%
32.8%
Q3 24
14.1%
29.8%
Q2 24
13.7%
26.1%
EPS (diluted)
BCPC
BCPC
CNS
CNS
Q1 26
$1.25
Q4 25
$1.21
$0.67
Q3 25
$1.24
$0.81
Q2 25
$1.17
$0.72
Q1 25
$1.13
$0.77
Q4 24
$1.03
$0.89
Q3 24
$1.03
$0.77
Q2 24
$0.98
$0.63

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCPC
BCPC
CNS
CNS
Cash + ST InvestmentsLiquidity on hand
$72.9M
$145.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.3B
$562.0M
Total Assets
$1.7B
$876.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCPC
BCPC
CNS
CNS
Q1 26
$72.9M
Q4 25
$74.6M
$145.5M
Q3 25
$65.1M
$98.1M
Q2 25
$65.4M
$95.4M
Q1 25
$49.9M
$65.2M
Q4 24
$49.5M
$183.0M
Q3 24
$73.7M
$106.5M
Q2 24
$63.7M
$122.0M
Stockholders' Equity
BCPC
BCPC
CNS
CNS
Q1 26
$1.3B
Q4 25
$1.3B
$562.0M
Q3 25
$1.3B
$550.3M
Q2 25
$1.3B
$528.5M
Q1 25
$1.2B
$507.7M
Q4 24
$1.1B
$511.7M
Q3 24
$1.2B
$491.0M
Q2 24
$1.1B
$463.2M
Total Assets
BCPC
BCPC
CNS
CNS
Q1 26
$1.7B
Q4 25
$1.7B
$876.7M
Q3 25
$1.7B
$801.6M
Q2 25
$1.7B
$751.0M
Q1 25
$1.6B
$834.9M
Q4 24
$1.6B
$812.4M
Q3 24
$1.6B
$727.8M
Q2 24
$1.6B
$784.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCPC
BCPC
CNS
CNS
Operating Cash FlowLast quarter
$40.1M
$-120.4M
Free Cash FlowOCF − Capex
$33.8M
$-126.4M
FCF MarginFCF / Revenue
12.5%
-87.9%
Capex IntensityCapex / Revenue
2.3%
4.2%
Cash ConversionOCF / Net Profit
0.99×
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCPC
BCPC
CNS
CNS
Q1 26
$40.1M
Q4 25
$67.3M
$-120.4M
Q3 25
$65.6M
$55.1M
Q2 25
$47.3M
$-67.6M
Q1 25
$36.5M
$-108.9M
Q4 24
$52.3M
$96.7M
Q3 24
$51.3M
$25.6M
Q2 24
$45.0M
$31.4M
Free Cash Flow
BCPC
BCPC
CNS
CNS
Q1 26
$33.8M
Q4 25
$-126.4M
Q3 25
$52.6M
Q2 25
$-69.8M
Q1 25
$-110.0M
Q4 24
$85.0M
Q3 24
$24.2M
Q2 24
$27.1M
FCF Margin
BCPC
BCPC
CNS
CNS
Q1 26
12.5%
Q4 25
-87.9%
Q3 25
37.1%
Q2 25
-51.3%
Q1 25
-81.8%
Q4 24
60.8%
Q3 24
18.2%
Q2 24
22.3%
Capex Intensity
BCPC
BCPC
CNS
CNS
Q1 26
2.3%
Q4 25
4.2%
Q3 25
1.8%
Q2 25
1.6%
Q1 25
0.8%
Q4 24
8.3%
Q3 24
1.1%
Q2 24
3.5%
Cash Conversion
BCPC
BCPC
CNS
CNS
Q1 26
0.99×
Q4 25
1.72×
-3.45×
Q3 25
1.63×
1.32×
Q2 25
1.23×
-1.84×
Q1 25
0.98×
-2.74×
Q4 24
1.56×
2.11×
Q3 24
1.52×
0.65×
Q2 24
1.40×
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons